A federal judge in Boston ruled last month that AstraZeneca, Bristol-Myers Squibb and Schering-Plough must pay damages for overcharging on certain drugs paid for by Medicare, pension funds, insurers and patients. The judge found the companies liable in a nationwide class action lawsuit over drugs administered by doctors. Claims were dismissed against Johnson & Johnson. The plaintiffs’ lawyers were given until August 1st to provide calculations of damages for the other companies. This was a typical “average wholesale price” case. The plaintiffs are seeking hundreds of millions of dollars in damages. In a 183-page opinion, the judge wrote:

The Medicare statute itself created a perverse incentive by pegging the nationwide reimbursement for billions of drug transactions a year to a price reported by the pharmaceutical industry, thus putting the proverbial pharmaceutical fox in charge of the reimbursement chicken coop. The different pharmaceutical companies unfairly took advantage of the system by setting sky-high prices with no relation to the marketplace.

The judge found that AstraZeneca, which is based in London, acted “unfairly and deceptively” by causing the publication of false and inflated average wholesale prices for its prostate cancer drug Zoladex, which exceeded doctors’ acquisition costs by as much as 169%. Bristol-Myers, of New York, caused the publication of false and inflated average wholesale prices for five drugs, including Taxol, which had spreads as high as 500%. Warrick, a subsidiary of Schering-Plough, which is based in Kenilworth, New Jersey, inflated average wholesale prices for its generic drug albuterol sulfate in a range of 100% to 800%. This is a most significant decision and one that will benefit our firm in the cases we are handling for several states.

 



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Louisiana AG discusses Medicaid Fraud litigation

Louisiana joins 27 other states in accusing the drug companies of misreporting prices, and estimates the...

Drug suit by state's AG shows he's looking out for...

Kansas Attorney General Steve Six filed suit Friday against 13 drug manufacturers, claiming the...

Alabama Settles with 2 in Drug Lawsuits

The state of Alabama will receive almost $7 million from a settlement with two drug manufacturers, who...

Federal Judge Doubles Damages in Drug Pricing Case

Pharmaceutical companies AstraZeneca and Bristol-Myers Squibb Company have been ordered to pay double...

Plaintiffs' Lawyers Tackle Drug Price-Fixing...

Plaintiffs' trial attorneys are taking on a new challenge: representing state attorneys general, health...

Alabama Supreme Court rules on State's Lawsuit against...

The Alabama Supreme Court sided with drug companies Friday in deciding how to try the state government's...

Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.

—Richard